Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial to Improve Care of Patients With Hereditary Cancer Syndromes

NCT06914726 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT06914726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06914726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial to Improve Care of Patients With Hereditary Cancer Syndromes
Lead sponsor
HealthPartners Institute
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 9, 2025
Completion date
March 31, 2029
Enrollment
2,488 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic variation, hboc syndrome, hereditary breast/ovarian cancer (brca1, brca2), hereditary cancer syndromes, lynch syndrome